Keerthana Manikandan

Keerthana Manikandan

Auto-generated profile, based on publicly available information

Keerthana Manikandan

Centre for Neuroscience, Indian Institute of Science, Bengaluru, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2020 in NeuroImage
Verified
Journal Article
Open access
DMDinavahi V.P.S. Murty
Dinavahi V.P.S. Murty
KMKeerthana Manikandan
Keerthana Manikandan
WKWupadrasta Santosh Kumar
Wupadrasta Santosh Kumar
RRRanjini Garani Ramesh
Ranjini Garani Ramesh
SPSimran Purokayastha
Simran Purokayastha
SRSupratim Ray
Supratim Ray
Gamma rhythms (~20-70 ​Hz) are abnormal in mental disorders such as autism and schizophrenia in humans, and Alzheimer's disease (AD) models in rodents. However, the effect of normal aging on these oscillations is unknown, especially for elderly subjects in whom AD is most prevalent. In a first large-scale (236 subjects; 104 females) electroencephalogram (EEG) study on gamma oscillations in elderly subjects (aged 50-88 years), we presented full-screen visual Cartesian gratings that induced two distinct gamma oscillations (slow: 20-34 ​Hz and fast: 36-66 ​Hz). Power decreased with age for gamma, but not alpha (8-12 ​Hz). Reduction was more salient for fast gamma than slow. Center frequency also decreased with age for both gamma rhythms. The results were independent of microsaccades, pupillary reactivity to stimulus, and variations in power spectral density with age. Steady-state visual evoked potentials (SSVEPs) at 32 ​Hz also reduced with age. These results are crucial for developing gamma/SSVEP-based biomarkers of cognitive decline in elderly.

8 June 2021 in eLife
Verified
Journal Article
Open access
DMDinavahi Vps Murty
Dinavahi Vps Murty
KMKeerthana Manikandan
Keerthana Manikandan
WKWupadrasta Santosh Kumar
Wupadrasta Santosh Kumar
RRRanjini Garani Ramesh
Ranjini Garani Ramesh
SPSimran Purokayastha
Simran Purokayastha
SRSupratim Ray
Supratim Ray
Alzheimer’s disease (AD) in elderly adds substantially to socioeconomic burden necessitating early diagnosis. While recent studies in rodent models of AD have suggested diagnostic and therapeutic value for gamma rhythms in brain, the same has not been rigorously tested in humans. In this case-control study, we recruited a large population (N = 244; 106 females) of elderly (>49 years) subjects from the community, who viewed large gratings that induced strong gamma oscillations in their electroencephalogram (EEG). These subjects were classified as healthy (N = 227), mild cognitively impaired (MCI; N = 12), or AD (N = 5) based on clinical history and Clinical Dementia Rating scores. Surprisingly, stimulus-induced gamma rhythms, but not alpha or steady-state visually evoked responses, were significantly lower in MCI/AD subjects compared to their age- and gender-matched controls. This reduction was not due to differences in eye movements or baseline power. Our results suggest that gamma could be used as a potential screening tool for MCI/AD in humans.

8 July 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
WKWupadrasta Santosh Kumar
Wupadrasta Santosh Kumar
KMKeerthana Manikandan
Keerthana Manikandan
DMDinavahi V.P.S. Murty
Dinavahi V.P.S. Murty
RRRanjini Garani Ramesh
Ranjini Garani Ramesh
SPSimran Purokayastha
Simran Purokayastha
SRSupratim Ray
Supratim Ray
Visual stimulus-induced narrowband gamma oscillations in electroencephalogram (EEG) recordings have been recently shown to be compromised in subjects with Mild Cognitive Impairment or Alzheimer’s Disease (AD), suggesting that gamma could be an inexpensive and easily accessible biomarker for early diagnosis of AD. However, to use gamma as a biomarker, its characteristics should remain consistent across multiple recordings, even when separated over long intervals. Previous magnetoencephalography studies in young subjects have reported that gamma power remains consistent over recordings separated by a few weeks to months. Here, we assessed the consistency of slow (20-35 Hz) and fast gamma (36-66 Hz) oscillations induced by static full-field gratings in male (N=20) and female (N=20) elderly subjects (>49 years) in EEG recordings separated by more than a year, and tested the consistency in the magnitude of gamma power, its temporal evolution and spectral profile. Gamma oscillations had distinct spectral and temporal characteristics across subjects, which remained consistent across recordings (average intraclass correlation, ICC of ∼0.7). Alpha oscillations (8-12 Hz) and steady-state-visually-evoked-potentials (SSVEPs) were also found to be reliable. We further tested how EEG features can be used to identify two recordings as belonging to the same versus different subjects and found high classifier performance (area under ROC curve of ∼0.89), with the temporal evolution of slow gamma and spectral profile emerging as the most informative features. These results suggest that EEG gamma oscillations are reliable across recordings and can be used as a clinical biomarker as well as a potential tool for subject identification. Significance statement We demonstrate the reliability of stimulus-induced gamma oscillations in elderly humans for the first time in EEG. Since gamma has recently been shown to be compromised in patients with Mild Cognitive Impairment or early Alzheimer’s Disease (AD), together these results mark the first steps towards an EEG based clinical biomarker for early diagnosis of AD. We observed high reliability in the power spectrum, gamma power and its temporal characteristics, within the test-retest period of one year. Alpha and steady-state-visually-evoked potential power were also found to be reliable. These spectral and temporal features could also be used to identify EEG recordings as belonging to the same versus different subjects with high performance, suggesting a potentially key role in subject identification also.

26 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
DMDinavahi V. P. S. Murty
Dinavahi V. P. S. Murty
KMKeerthana Manikandan
Keerthana Manikandan
RRRanjini Garani Ramesh
Ranjini Garani Ramesh
SPSimran Purokayastha
Simran Purokayastha
BNBhargavi Nagendra
Bhargavi Nagendra
SRSupratim Ray
Supratim Ray
Alzheimer’s Disease (AD) in elderly adds substantially to socio-economic burden necessitating early diagnosis. While recent studies in rodent models of AD have suggested diagnostic and therapeutic value for gamma rhythms in brain, the same has not been rigorously tested in humans. We recruited a large population (N=247; 106 females) of elderly (>49 years) individuals from the community, who viewed large gratings that induced strong gamma oscillations in their electroencephalogram (EEG). These individuals were classified as healthy (N=227), mild-cognitively-impaired (MCI; 14) or AD (6) based on clinical history and Clinical Dementia Rating scores. Surprisingly, stimulus-induced gamma rhythms, but not alpha or steady-state-visually-evoked-responses, were significantly lower in both MCI and AD patients compared to their age and gender matched controls. This reduction was not due to differences in eye movements or baseline power. Our results suggest that gamma could be used as potential diagnostic tool for MCI/AD in humans. One Sentence Summary: A large double-blinded EEG study suggests that narrow-band visual gamma rhythms are weaker in MCI/AD patients compared to cognitively healthy controls.